| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms D Malkin, FP Li, LC Strong, JF Fraumeni Jr, CE Nelson, DH Kim, J Kassel, ... Science 250 (4985), 1233-1238, 1990 | 4940 | 1990 |
| Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma J Schwartzentruber, A Korshunov, XY Liu, DTW Jones, E Pfaff, K Jacob, ... Nature 482 (7384), 226-231, 2012 | 2629 | 2012 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 962 | 2012 |
| Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations T Rausch, DTW Jones, M Zapatka, AM Stütz, T Zichner, J Weischenfeldt, ... Cell 148 (1), 59-71, 2012 | 928 | 2012 |
| Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency E Bouffet, V Larouche, BB Campbell, D Merico, R De Borja, M Aronson, ... Journal of clinical oncology 34 (19), 2206-2211, 2016 | 831 | 2016 |
| Comprehensive analysis of hypermutation in human cancer BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ... Cell 171 (5), 1042-1056. e10, 2017 | 696 | 2017 |
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445-450, 2014 | 633 | 2014 |
| Medulloblastoma PA Northcott, GW Robinson, CP Kratz, DJ Mabbott, SL Pomeroy, ... Nature reviews Disease primers 5 (1), 11, 2019 | 520 | 2019 |
| Li–Fraumeni syndrome D Malkin Adrenocortical Carcinoma: Basic Science and Clinical Concepts, 173-191, 2010 | 518 | 2010 |
| Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ... Journal of Clinical Oncology 31 (23), 2927-2935, 2013 | 510 | 2013 |
| Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study A Villani, A Shore, JD Wasserman, D Stephens, RH Kim, H Druker, ... The Lancet Oncology 17 (9), 1295-1305, 2016 | 476 | 2016 |
| Cancer screening recommendations for individuals with Li-Fraumeni syndrome CP Kratz, MI Achatz, L Brugieres, T Frebourg, JE Garber, MLC Greer, ... Clinical Cancer Research 23 (11), e38-e45, 2017 | 459 | 2017 |
| Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms D Malkin, KW Jolly, N Barbier, AT Look, SH Friend, MC Gebhardt, ... New England Journal of Medicine 326 (20), 1309-1315, 1992 | 447 | 1992 |
| Copy number variations and cancer A Shlien, D Malkin Genome medicine 1, 1-9, 2009 | 436 | 2009 |
| Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers KE Nichols, D Malkin, JE Garber, JF Fraumeni Jr, FP Li Cancer Epidemiology Biomarkers & Prevention 10 (2), 83-87, 2001 | 424 | 2001 |
| Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples PA Northcott, DJH Shih, M Remke, YJ Cho, M Kool, C Hawkins, ... Acta neuropathologica 123, 615-626, 2012 | 421 | 2012 |
| Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study A Villani, U Tabori, J Schiffman, A Shlien, J Beyene, H Druker, ... The lancet oncology 12 (6), 559-567, 2011 | 409 | 2011 |
| Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ... elife 3, e02935, 2014 | 397 | 2014 |
| Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations LB Travis, CS Rabkin, LM Brown, JM Allan, BP Alter, CB Ambrosone, ... Journal of the National Cancer Institute 98 (1), 15-25, 2006 | 393 | 2006 |
| Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers A Shlien, BB Campbell, R De Borja, LB Alexandrov, D Merico, D Wedge, ... Nature genetics 47 (3), 257-262, 2015 | 370 | 2015 |
